Best Health Degrees Releases National Rankings of Radiation Sciences Master s Programs prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Adrienne Smith of Gridiron Queendom: “Public relations strategy is critical”
Public relations strategy is critical. You can have the best game on Earth, Mars and Venus, but if no one knows about your game, then you have nothing. Find a good PR partner and secure coverage across a variety of media to garner the highest possible amount of interest from your different target audiences. As […]
The Thrive Global Community welcomes voices from many spheres on our open platform. We publish pieces as written by outside contributors with a wide range of opinions, which don’t necessarily reflect our own. Community stories are not commissioned by our editorial team and must meet our guidelines prior to being published.
The Centers for Disease Control and Prevention is investing $200 million in a new genome-sequencing pilot program to ramp up surveillance of COVID-19 variants, the administration announced Wednesday. The initiative will be run out of and overseen by the federal agency, but will rely on partnerships from other academic and scientific institutions, officials said. National Testing Coordinator Carol Johnson said the program will attempt to scale.
World-leading Breast Cancer Oncologists Cynthia Ma MD, PhD and Massimo Cristofanilli, MD to Join Olaris Scientific and Medical Advisory Board
Share Article
Drs. Cynthia Ma and Massimo Cristofanilli to Advise on Biomarkers of Response (BoRs) to Drive Better Treatment Outcomes for Patients with Breast Cancer
I am impressed by Olaris’s technology and early data suggesting the potential use of a metabolomics signature as an independent and robust predictive biomarker in metastatic breast cancer. - Dr. Cristofanilli WALTHAM, Mass. (PRWEB) February 16, 2021 Olaris, Inc, a precision medicine company leveraging metabolomics and machine learning for the discovery and development of Biomarkers of Response (BoRs) to optimize treatments and patient outcomes, has appointed Dr. Cynthia Ma of Washington University in St. Louis and Dr. Massimo Cristofanilli from Northwestern Medicine to its Scientific Advisory Board and Medic